The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Abrahmsen Lars B. since 2021.
This trader's CIK number is 1789039.
At the time of last reporting, Abrahmsen Lars B. was the SVP, Chief Scientific Officer of Aprea Therapeutics, Inc.. (stock ticker symbol APRE).
Also see all insider trading activities at Aprea Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | APRE | 0 | $0 | 75,000 | $368,749 | 75,000 | $69,000 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-10-01 | APRE | Sale | 50,000 | 4.89 | 244,499 |
| 2021-10-01 | APRE | Option Ex | 50,000 | .92 | 46,000 |
| 2021-09-20 | APRE | Sale | 25,000 | 4.97 | 124,250 |
| 2021-09-20 | APRE | Option Ex | 25,000 | .92 | 23,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Abrahmsen Lars B. (SVP, Chief Scientific Officer of Aprea Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.